X @Bloomberg
Bloomberg·2026-01-28 14:23
Regenxbio shares sank after US regulators placed a hold on the company’s gene therapy trials because a patient was found to have a brain tumor https://t.co/T4dqJ9omx9 ...
Regenxbio shares sank after US regulators placed a hold on the company’s gene therapy trials because a patient was found to have a brain tumor https://t.co/T4dqJ9omx9 ...